Neuravi raises 15 million euros to boost new thrombus removal equipment into the US market November 09, 2016 Source: Bio Valley Disposable Suction And Irrigation Sets
A Disposable Suction Irrigator Kit is a medical device used during surgery to remove blood, debris, and other fluids from the surgical site. The kit usually includes a straw and rinse tube, both of which are disposable and designed to be used only once. Suction tubing is used to remove fluid from the surgical site, while irrigation tubing is used to introduce sterile saline or other solutions to the surgical site to help clean and irrigate the area. The single-use nature of the kit helps reduce the risk of infection and cross-contamination between patients.
3.Fully transparent pipeline design provides the best way for suction observation operation;
Disposable Suction And Irrigation Sets,Medical Suction And Irrigation System,Sterile Disposable Suction Sleeve,Medical Tube Suction Tube Set Changzhou Weipu Medical Devices Co., Ltd. , https://www.cnweipumedical.com
Product features of disposable suction and irrigation equipment:
1. Dual functions of flushing and suction, one machine with multiple functions;
2. The flushing and suction functions are clearly distinguished, and the operation is simple, one-handed operation, convenient and fast;
4.The front and rear ends are detachable, which facilitates the absorption of foreign bodies during the operation.
Neuravi raises 15 million euros to boost new thrombus removal equipment into the US market
Neuravi, an Irish medical device company, recently announced that it has received a total of $15 million in financing from IPF Partners to help its cerebral thrombectomy device EmboTrap land in the US market. The device was approved for entry into the European market last year and the second generation of the product was released last month. EmboTrap's main competitors are Solitaire under Medtronic and Trevo ProVue under Stryker.
EmboTrap was approved for the treatment of acute ischemic stroke. The device is capable of treating a patient by removing normal blood flow from blood clots in the blood vessels of the brain. The funds will be used to recruit patients in the United States and conduct a clinical study called ARISE II.
The company said that if the product can quickly enter the US market, EmboTrap will bring considerable returns to the company. It is estimated that the current market for thrombus removal equipment in the United States is nearly $1 billion, and the scale of trial production will increase to $1.4 billion in 2014. And EmboTrap, Solitaire and Trevo are expected to lead the world in the future.
Neuravi also said that compared to Solitaire and Trevo, EmboTrap has significant advantages, such as the ability to completely remove blood clots, avoiding other safety problems caused by residual blood clots, and the device can restore blood flow to the blood vessels before the blood clots clear. Helps patients with treatment.
Acute ischemic stroke accounts for more than 87% of all stroke events and is the leading cause of death and disability in stroke. According to statistics, the number of patients with acute ischemic stroke in Europe and the United States is 1 million and 700,000 respectively. In the United States alone, the estimated cost of treatment for the disease has reached as much as $65 billion.
In recent years, clinical studies have found that mechanical methods have been used to remove blocked blood vessels to treat strokes with good results. Such methods are included in guidelines published by the American College of Cardiology. This has also led to a gradual increase in the use of such medical devices.